1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,376 | 0,477 | 17:47 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 04.11.25 | Scandinavian ChemoTech AB: Scandinavian ChemoTech AB (publ) publishes Interim Report Q3 2025 | 99 | GlobeNewswire (Europe) | The report is attached to this press release and can also be downloaded from the company's website.
July - September 2025 ... ► Artikel lesen | |
| 17.10.25 | Scandinavian ChemoTech AB: Scandinavian ChemoTech's Animal Care Surpasses 3,000 Treatments Performed Worldwide | 136 | GlobeNewswire (Europe) | Scandinavian ChemoTech's Animal Care, a pioneer in making oncology care more compassionate and human for animals, proudly announces another achievement: over 3,000 treatments have now been performed... ► Artikel lesen | |
| 01.10.25 | Scandinavian ChemoTech AB: ChemoTech's Animal Care Reports Strong Q3 Sales, Surpassing Expectations Despite Seasonal Slowdown | 133 | GlobeNewswire (Europe) | Scandinavian ChemoTech AB's Animal Care division is proud to announce another strong quarter, generating sales of USD 340,000 in Q3 2025. This result is within USD 50,000 of the company's record-breaking... ► Artikel lesen | |
| SCANDINAVIAN CHEMOTECH Aktie jetzt für 0€ handeln | |||||
| 26.09.25 | Scandinavian ChemoTech AB: ChemoTech's Animal Care Successfully Enters Swiss Market as Part of DACH Expansion | 478 | GlobeNewswire (Europe) | Scandinavian ChemoTech and its subsidiary VQ Animal Care Inc. is pleased to announce that it has officially started marketing vetIQure, its Tumor Specific Electroporation (TSE) technology in Switzerland.... ► Artikel lesen | |
| 19.09.25 | Scandinavian ChemoTech Hosts Successful TSE Best Practice Sharing Session with Dr. Brendan Boostrom | 1 | Cision News | ||
| 10.09.25 | Scandinavian ChemoTech AB: ChemoTech Expands in Illinois as 8th Clinic within Major U.S. Veterinary Group Adopts TSE Technology | 117 | GlobeNewswire (Europe) | Scandinavian ChemoTech AB today announced that its veterinary subsidiary, VQ Animal Care Inc., has secured a new partnership in Illinois. With this latest order, the eighth clinic within one of the... ► Artikel lesen | |
| 25.08.25 | Scandinavian ChemoTech Expands in Florida with Fourth Veterinary Oncology Clinic Partnership | 2 | Cision News | ||
| 20.08.25 | Scandinavian ChemoTech's Animal Care Surpasses 2,500 Treatment-kits sold Worldwide | 2 | Cision News | ||
| 12.08.25 | Scandinavian ChemoTech AB: Scandinavian ChemoTech AB (publ) publishes Interim Report Q2 2025 | 161 | GlobeNewswire (Europe) | Second quarter sales reached 3,841 KSEK, which is the best quarter so far. All sales originated from Animal Care. The report is attached to this press release and can also be downloaded from the company's... ► Artikel lesen | |
| 29.07.25 | Scandinavian ChemoTech Welcomes Strategic Investors from the announce Directed Share Issue to Accelerate Global Growth | 2 | Cision News | ||
| 27.07.25 | Scandinavian ChemoTech AB (publ) carries out a directed share issue and receives approximately 4.85 MSEK | 2 | Cision News | ||
| 25.07.25 | (RETRANS) Scandinavian ChemoTech's TSE Treatment Shows High Response Rate in Veterinary Cancer Study - Validated by Approved PhD Dissertation | 1 | Cision News | ||
| 24.07.25 | Scandinavian ChemoTech's TSE Treatment Shows High Response Rate in Veterinary Cancer Study - Validated by Approved PhD Dissertation | 1 | Cision News | ||
| 01.07.25 | Scandinavian ChemoTech AB: Scandinavian ChemoTech's Animal Care Division Achieves Record-Breaking Sales in Q2 2025 | 175 | GlobeNewswire (Europe) | Scandinavian ChemoTech AB's Animal Care division proudly announces record-breaking sales in the second quarter of 2025. With continued momentum from a strong start to the quarter, the team achieved... ► Artikel lesen | |
| 06.05.25 | Scandinavian ChemoTech AB: Scandinavian ChemoTech AB (publ) publishes Interim Report Q1 2025 | 169 | GlobeNewswire (Europe) | Scandinavian ChemoTech AB (publ) hereby publishes the Interim Report for Q1 2025.
First-quarter sales reached 2 472 KSEK, which is the best quarter so far. All sales originated from Animal Care.
First... ► Artikel lesen | |
| 04.03.25 | Scandinavian ChemoTech AB: Scandinavian ChemoTech AB (publ) publishes Year-End Report January - December 2024 | 182 | GlobeNewswire (Europe) | Scandinavian ChemoTech AB (publ) hereby publishes the Year-End Report for 2024.
Fourth-quarter sales reached 2 041 KSEK, which is the best quarter in 2024. Total annual sales amounted to 6 566 KSEK-entirely... ► Artikel lesen | |
| 30.01.25 | Scandinavian ChemoTech AB: Scandinavian ChemoTech Restructures Loans and Doubles the Duration to 12 Months | 233 | GlobeNewswire (Europe) | ChemoTech is pleased to announce the signing of new restructured loan agreements to replace its previous short-term bridge financing. The new agreements include a 2.4 MSEK loan from two external investors... ► Artikel lesen | |
| 24.01.25 | Scandinavian ChemoTech AB: Scandinavian ChemoTech's Animal Care operations showed positive cashflow for 2024 in separate reporting | 275 | GlobeNewswire (Europe) | Scandinavian ChemoTech is pleased to announce that our Animal Care operations would already be showing a positive cash flow if we reported our business areas separately. This underscores the importance... ► Artikel lesen | |
| 09.01.25 | Scandinavian ChemoTech AB: Scandinavian ChemoTech Implements Management Changes to Reduce Costs and Boost Revenues | 204 | GlobeNewswire (Europe) | Scandinavian ChemoTech AB, in line with the structural changes for the group published on December 30, 2024, has decided to implement measures aimed at achieving financial sustainability. As part of... ► Artikel lesen |
19 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 44,310 | -1,36 % | JEFFERIES stuft Siemens Healthineers auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Siemens Healthineers vor Zahlen zum ersten Geschäftsquartal auf "Buy" mit einem Kursziel von 60 Euro belassen. Der Medizintechnikkonzern... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,100 | -1,62 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| FRESENIUS | 47,770 | -2,47 % | Amneal Pharma, MAbxience: FDA Approves Denosumab Biosimilars Referencing Amgen's Prolia And XGEVA | THOUSAND OAKS (dpa-AFX) - Amneal Pharmaceuticals, Inc. (AMRX) announced late Monday that the U.S. Food and Drug Administration has approved the Biologics Licensing Applications or BLAs for Boncresa... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 39,360 | -1,60 % | EILMELDUNG: Carl Zeiss Meditec-Aktie stabil - Marktbeobachter rechnen mit Bewegung. | ||
| UNITEDHEALTH | 287,95 | +2,77 % | ROUNDUP/Aktien New York: Kaum verändert am vorletzten Handelstag des Jahres | NEW YORK (dpa-AFX) - Bei den wichtigsten US-Aktienindizes hat sich am Dienstag am vorletzten Handelstag des Jahres wenig getan. Der Dow Jones Industrial sank im frühen Handel um 0,08 Prozent auf 48.423... ► Artikel lesen | |
| ECKERT & ZIEGLER | 15,050 | -1,38 % | ECKERT & ZIEGLER SE - Stabilität als strategische Basis | ||
| GERRESHEIMER | 27,820 | +0,87 % | Comeback 2026! Verzehnfachung möglich? Evotec, Gerresheimer, Desert Gold Aktie! | Auf der Suche nach einem möglichen Verzehnfacher im Gold-Sektor? Dies halten Analysten bei Desert Gold für möglich. Die jüngste PEA für das Flaggschiff-Gold-Projekt löst neue Kursfantasie aus. Damit... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 37,550 | +0,27 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P SmallCap 600 | NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective... ► Artikel lesen | |
| GENEDX | 136,44 | +4,91 % | GeneDx to Participate in Upcoming Investor Conferences | GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences:
Stifel... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 20,020 | +1,32 % | Alignment Healthcare Reports Third Quarter 2025 Results, Surpasses High-End of Guidance Across All Key Metrics | Reports Q3 revenue of $993.7 million, up 43.5% year-over-yearBeats high end of third quarter guidance and raises full-year outlook across all key metrics: membership, revenue, adjusted gross profit... ► Artikel lesen | |
| OTTOBOCK | 65,75 | +0,77 % | IPO-Rückblick 2025: TKMS, Klarna, Ottobock und Circle im Anleger-Check | Guten Tag, liebe Leserinnen und Leser,
2025 war ein vergleichsweise starkes Jahr für Neuemissionen. Allein in der ersten Jahreshälfte wagten weltweit 539 Unternehmen den Schritt an die Börse und sammelten... ► Artikel lesen | |
| PROGYNY | 25,920 | +0,90 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 7,755 | -5,08 % | Aveanna Healthcare Holdings, Inc: Aveanna Healthcare Holdings Announces Third Quarter Financial Results and Revised 2025 Outlook | Third Quarter Revenue was $621.9 million, a 22.2% increase over the prior year periodThird Quarter Net income was $14.1 million compared to Net loss of $42.8 million for the prior year periodAdjusted... ► Artikel lesen | |
| BETA BIONICS | 29,510 | -3,15 % | Beta Bionics, Inc.: Beta Bionics Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Guidance | IRVINE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| ESSILORLUXOTTICA | 265,10 | -2,14 % | You can buy Meta Ray-Ban glasses for 25% off right now - here's where |
Das Unternehmen SCANDINAVIAN CHEMOTECH AB kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell -0,96 % bei einem Aktienkurs von 0,414 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SCANDINAVIAN CHEMOTECH AB finden Sie auf Wallstreet Online.